Uric Acid Nephropathy Gout — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for uric acid nephropathy gout. 16 active patents protecting 1 drugs from 1+ originators. First major cliff: 2028. Daily refresh.

1
Approved drugs
16
Active US patents
63/100
Avg vulnerability
—
Annual revenue covered

Originators in Uric Acid Nephropathy Gout

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Casper Pharma Llc 16 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating uric acid nephropathy gout. Each bar = one year. Y-axis scaled to peak year (6 patents).

4
28
6
29
4
31
2
32

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Aloprim
ALLOPURINOL
 Casper Pharma Llc 16 63 — 2028-11-26

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8283369 Aloprim method of use 75 2028-11-26
10183012 Aloprim method of use 75 2028-11-26
10183012 Aloprim method of use 75 2028-11-26
8283369 Aloprim method of use 75 2028-11-26
8546437 Aloprim method of use 75 2029-04-29
8546437 Aloprim method of use 75 2029-04-29
8084483 Aloprim method of use 68 2029-08-17
8084483 Aloprim method of use 68 2029-08-17
8357713 Aloprim method of use 68 2029-12-22
8357713 Aloprim method of use 68 2029-12-22

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8546436 Aloprim composition of matter 10 2032-02-29
8546436 Aloprim composition of matter 10 2032-02-29
9956205 Aloprim method of use 68 2031-12-28
9956205 Aloprim method of use 68 2031-12-28
9216179 Aloprim method of use 68 2031-08-01
9216179 Aloprim method of use 68 2031-08-01
8357713 Aloprim method of use 68 2029-12-22
8357713 Aloprim method of use 68 2029-12-22
8084483 Aloprim method of use 68 2029-08-17
8084483 Aloprim method of use 68 2029-08-17

Related